Suresh V Ambudkar Selected Research

becatecarin (XL 119)

8/2009

Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suresh V Ambudkar Research Topics

Disease

108	Neoplasms (Cancer) 05/2022 - 08/2002
24	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2007
8	Carcinoma (Carcinomatosis) 12/2011 - 08/2002
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 10/2010
4	Colonic Neoplasms (Colon Cancer) 11/2021 - 01/2006
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2017 - 02/2009
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2014 - 08/2010
3	Stroke (Strokes) 12/2007 - 09/2006
3	Alcoholism (Alcohol Abuse) 07/2005 - 03/2004
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2017
2	Adenocarcinoma 11/2019 - 11/2014
2	Cardiotoxicity 01/2017 - 01/2017
2	Melanoma (Melanoma, Malignant) 02/2013 - 06/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2013 - 06/2012
2	Carcinogenesis 10/2012 - 12/2007
1	Multiple Myeloma 03/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Rheumatoid Arthritis 01/2019
1	Alcoholic Fatty Liver 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019

Drug/Important Bio-Agent (IBA)

49	Pharmaceutical PreparationsIBA 01/2022 - 08/2002
44	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2022 - 08/2002
43	Adenosine Triphosphate (ATP)IBA 05/2022 - 10/2003
39	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2021 - 08/2006
26	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2007
9	multidrug resistance-associated protein 1IBA 01/2021 - 03/2004
8	Tyrosine Kinase InhibitorsIBA 01/2021 - 11/2007
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 09/2007
7	Phosphotransferases (Kinase)IBA 01/2017 - 08/2011
5	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2019 - 02/2007
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 11/2007
4	tariquidar (XR9576)IBA 10/2020 - 06/2010
4	Biological ProductsIBA 01/2020 - 10/2003
4	Topotecan (Hycamtin)FDA LinkGeneric 01/2019 - 08/2009
4	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 10/2010
4	CurcuminIBA 11/2017 - 08/2002
3	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 11/2021 - 11/2014
3	Colchicine FDA LinkGeneric 11/2019 - 09/2007
3	nilotinib FDA Link 07/2014 - 08/2011
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2013 - 07/2007
3	Disulfiram (Antabuse)FDA Link 07/2005 - 03/2004
2	PorphyrinsIBA 01/2022 - 10/2019
2	OTS964IBA 01/2022 - 01/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 08/2009
2	Photosensitizing Agents (Photosensitizers)IBA 09/2021 - 10/2019
2	Histone Deacetylase 6IBA 03/2021 - 01/2018
2	Therapeutic UsesIBA 01/2021 - 07/2005
2	Phosphodiesterase 5 InhibitorsIBA 01/2020 - 04/2011
2	Drug CombinationsIBA 01/2020 - 01/2020
2	LipidsIBA 10/2019 - 08/2010
2	regorafenibIBA 01/2019 - 01/2017
2	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 02/2012
2	Cisplatin (Platino)FDA LinkGeneric 02/2016 - 09/2007
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2015 - 02/2009
2	BI 2536IBA 10/2013 - 01/2013
2	Lapatinib (GW572016)FDA Link 10/2013 - 10/2008
2	sipholenol AIBA 11/2010 - 09/2007
2	Vinblastine (Vinblastine Sulfate)FDA Link 11/2010 - 09/2007
2	Cytotoxins (Cytolysins)IBA 11/2010 - 09/2007
2	TriterpenesIBA 11/2010 - 09/2007
2	NSC73306IBA 12/2007 - 05/2006
1	Anaplastic Lymphoma KinaseIBA 05/2022
1	ensartinibIBA 05/2022
1	TAK-243IBA 01/2022
1	AntibodiesIBA 09/2021
1	citarinostatIBA 03/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2021
1	aumolertinibIBA 01/2021
1	1,2,3,4-tetrahydroquinolineIBA 01/2021
1	branebrutinibIBA 01/2021
1	indoleIBA 01/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021
1	IndolesIBA 01/2021
1	LY3023414IBA 10/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	ARQ 197IBA 01/2020
1	LigandsIBA 01/2020
1	licochalcone AIBA 01/2020
1	MY 5445IBA 01/2020
1	Chalcone (Benzalacetophenone)IBA 01/2020
1	sitravatinibIBA 01/2020
1	Histone Deacetylase InhibitorsIBA 12/2019
1	TMP195IBA 12/2019
1	XenobioticsIBA 12/2019
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2019
1	glesatinibIBA 01/2019
1	MAP Kinase Kinase Kinase 5IBA 01/2019
1	midostaurinIBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	avapritinibIBA 01/2019
1	Adenosine Triphosphatases (ATPase)IBA 01/2019
1	Multidrug Resistance-Associated ProteinsIBA 01/2019
1	Purinergic P1 Receptor AgonistsIBA 01/2019
1	selonsertibIBA 01/2019

Therapy/Procedure

34	Drug Therapy (Chemotherapy) 11/2021 - 08/2005
18	Therapeutics 01/2022 - 09/2004
2	Combination Drug Therapy (Combination Chemotherapy) 01/2017 - 02/2013
1	Photochemotherapy (Photodynamic Therapy) 10/2019